Daiichi-Sankyo's Injectafer Patient Assistance Programs.
- Published in:
- 2018
- Publication type:
- Product Review
Works matching DE "DAIICHI Sankyo Co. Ltd."
Results: 2
1
2
Olmesartan triple combination is effective and well tolerated among varied population groups, according to TRINITY subanalyses.
- Published in:
- Expert Review of Clinical Pharmacology, 2011, v. 4, n. 4, p. 414
- Publication type:
- Article